Citizens Business Bank Bristol Myers Squibb CO Transaction History

Citizens Business Bank

  • $460 Million
  • Q2 2024

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $155,572 - $185,640
-3,209 Reduced 34.96%
5,970 $306,000
Q3 2023

Nov 02, 2023
SELL
$57.89 - $64.73 $14,761 - $16,506
-255 Reduced 2.7%
9,179 $532,000
Q2 2023

Aug 07, 2023
BUY
$63.71 - $70.74 $174,883 - $194,181
2,745 Added 41.04%
9,434 $603,000
Q1 2023

May 09, 2023
BUY
$65.71 - $74.53 $32,657 - $37,041
497 Added 8.03%
6,689 $463,000
Q4 2022

Feb 07, 2023
BUY
$68.48 - $81.09 $4,451 - $5,270
65 Added 1.06%
6,192 $445,000
Q3 2022

Nov 03, 2022
BUY
$0.13 - $76.84 $796 - $470,798
6,127 New
6,127 $435,000
Q2 2022

Nov 18, 2022
SELL
$72.62 - $79.98 $32,461 - $35,751
-447 Reduced 0.82%
54,245 $4.18 Million
Q1 2022

Nov 18, 2022
BUY
$61.48 - $73.72 $2.11 Million - $2.53 Million
34,277 Added 167.9%
54,692 $4 Million
Q4 2021

Nov 18, 2022
SELL
$53.63 - $62.52 $70,094 - $81,713
-1,307 Reduced 6.02%
20,415 $1.27 Million
Q3 2021

Nov 18, 2022
BUY
$59.17 - $69.31 $9,526 - $11,158
161 Added 0.75%
21,722 $1.29 Million
Q2 2021

Nov 18, 2022
BUY
$61.91 - $67.42 $1,176 - $1,280
19 Added 0.09%
21,561 $1.44 Million
Q1 2021

Nov 18, 2022
SELL
$59.34 - $66.74 $63,493 - $71,411
-1,070 Reduced 4.73%
21,542 $1.36 Million
Q4 2020

Nov 18, 2022
BUY
$57.74 - $65.43 $288 - $327
5 Added 0.02%
22,612 $1.4 Million
Q3 2020

Nov 18, 2022
SELL
$57.43 - $63.64 $28,715 - $31,820
-500 Reduced 2.16%
22,607 $1.36 Million
Q2 2020

Nov 18, 2022
BUY
$54.82 - $64.09 $232,765 - $272,126
4,246 Added 22.51%
23,107 $1.36 Million
Q1 2020

Nov 18, 2022
SELL
$46.4 - $67.43 $3,480 - $5,057
-75 Reduced 0.4%
18,861 $1.05 Million
Q4 2019

Nov 18, 2022
SELL
$49.21 - $64.19 $24,752 - $32,287
-503 Reduced 2.59%
18,936 $1.22 Million
Q3 2019

Nov 18, 2022
SELL
$42.77 - $50.71 $13,558 - $16,075
-317 Reduced 1.6%
19,439 $985,000
Q2 2019

Nov 18, 2022
BUY
$44.62 - $49.34 $48,457 - $53,583
1,086 Added 5.82%
19,756 $896,000
Q1 2019

Nov 18, 2022
BUY
$45.12 - $53.8 $10,016 - $11,943
222 Added 1.2%
18,670 $891,000
Q4 2018

Nov 18, 2022
SELL
$48.76 - $63.23 $536,360 - $695,530
-11,000 Reduced 37.35%
18,448 $959,000
Q3 2018

Nov 18, 2022
BUY
$55.19 - $62.25 $4,194 - $4,731
76 Added 0.26%
29,448 $1.83 Million
Q2 2018

Nov 18, 2022
SELL
$50.53 - $62.98 $35,371 - $44,086
-700 Reduced 2.33%
29,372 $1.63 Million
Q1 2018

Nov 18, 2022
SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 0.33%
30,072 $1.9 Million
Q3 2017

Nov 18, 2022
SELL
$55.23 - $63.74 $298,518 - $344,514
-5,405 Reduced 15.19%
30,172 $1.92 Million
Q2 2017

Nov 18, 2022
BUY
N/A
29,450 Added 480.66%
35,577 $1.98 Million
Q4 2016

Nov 18, 2022
SELL
N/A
-10,424 Reduced 22.45%
36,003 $2.1 Million
Q3 2016

Nov 18, 2022
BUY
N/A
377 Added 0.82%
46,427 $2.5 Million
Q2 2016

Nov 18, 2022
BUY
N/A
73 Added 0.16%
46,050 $3.39 Million
Q1 2016

Nov 18, 2022
SELL
N/A
-4,864 Reduced 9.57%
45,977 $2.94 Million
Q3 2015

Nov 18, 2022
SELL
N/A
-350 Reduced 0.68%
50,841 $3.01 Million
Q2 2015

Nov 18, 2022
SELL
N/A
-895 Reduced 1.72%
51,191 $3.41 Million
Q1 2015

Nov 18, 2022
BUY
N/A
164 Added 0.32%
52,086 $3.36 Million
Q4 2014

Nov 18, 2022
SELL
N/A
-360 Reduced 0.69%
51,922 $3.06 Million
Q3 2014

Nov 18, 2022
BUY
N/A
171 Added 0.33%
52,282 $2.68 Million
Q2 2014

Nov 18, 2022
SELL
N/A
-5,250 Reduced 9.15%
52,111 $2.53 Million
Q1 2014

Nov 18, 2022
SELL
N/A
-9,196 Reduced 13.82%
57,361 $2.98 Million
Q4 2013

Nov 18, 2022
BUY
N/A
650 Added 0.99%
66,557 $3.54 Million
Q3 2013

Nov 18, 2022
SELL
N/A
-93 Reduced 0.14%
65,907 $3.05 Million
Q1 2013

Nov 18, 2022
BUY
N/A
3,500 Added 5.6%
66,000 $2.72 Million
Q4 2012

Nov 18, 2022
BUY
N/A
56,373
62,500 $2.04 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email